October 27 from 1:30 pm – 2:15 pm CDT
Innovation Theater B, Marriott Marquis | Developed and offered by Bristol Myers Squibb
Program Description
As a rheumatologist, you have the potential to play a key role in identifying patients with rheumatic disease who may be research candidates for CAR T-cell therapy and guiding them through each step of the process. In this interactive, discussion-focused session, our panel of CAR T-experienced clinicians will provide a practical guide that will enable you to help your patients, who are research candidates or participants, navigate each step of the CAR T-cell therapy journey.
Disclaimer: CAR T-cell therapy is not approved for the treatment of autoimmune diseases in any country and is currently an investigational therapy undergoing evaluation in clinical trials
Speakers:
Moderator: Grace C Wright, MD, PhD
Association of Women in Rheumatology
President
New York, New York
Panelist: Emily Littlejohn, DO, MPH
Cleveland Clinic Lerner College of Medicine
Director, Lupus Clinic; Associate Professor of Medicine
Cleveland, Ohio
Panelist: Paolo F Caimi, MD
Cleveland Clinic Lerner College of Medicine
Associate BMT Director for Cell Therapy; Associate Professor of Medicine
Cleveland, Ohio